Prescription Drug Price Transparency
Summary
Prescription Drug Price Transparency; Prohibits renewal of permits for prescription drug manufacturers & wholesale distributors unless specified requirements are met; provides reporting requirements for entities that engage in wholesale distributions of prescription drugs; provides requirements for notifications by manufacturers of prescription drug price increases; provides reporting requirements by manufacturers of drug prices; prohibits prescription drugs from being included in specified drug formularies; provides penalties & fines for violations; provides reporting requirements for registered pharmacy benefit managers; requires health insurers & HMOs to notify insureds & subscribers of drug formulary changes; requires pharmacy benefit managers to maintain a website for access to net prices of prescription drugs.
Bill status
died
1 of 4 stages cleared
Introduction
Jan 2022
Committee Review
Floor Vote
Governor
Introduced Jan 11, 2022
Last action Mar 14, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
8
Key actions
1
Committee
4
Jan 10, 2022
Lower · Passed
Now in Finance & Facilities Subcommittee
lower
Jan 10, 2022
Committee
Referred to Health & Human Services Committee
lower
Jan 10, 2022
Committee
Referred to Appropriations Committee
lower
Jan 10, 2022
Committee
Referred to Finance & Facilities Subcommittee
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Melony M. Bell
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 1183
Scope: FL
Hi! I can help you understand HB 1183. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline